GeneTether Therapeutics Inc., a biopharmaceutical company, focuses on the development of precision gene editing therapies based on its GeneTether platform for human therapeutics applications. It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases. The company was founded in 2018 and is based in Kelowna, Canada.